Discovering LINC02874: A Non-Coding RNA Molecule as A Potential Drug Target

Target Name: LINC02874

NCBI ID: G283403

Other Name(s): C12orf80 | long intergenic non-protein coding RNA 2874 | Uncharacterized protein LOC283403 | Chromosome 12 open reading frame 80

Discovering LINC02874: A Non-Coding RNA Molecule as A Potential Drug Target

LINC02874 (C12orf80) is a non-coding RNA molecule that has been identified as a potential drug target (or biomarker) for the treatment of various diseases, including cancer. The molecule is derived from the genomic region of chromosome 12 and has been shown to play a role in the regulation of cell growth, apoptosis, and inflammation.

The discovery of LINC02874 as a potential drug target was made by a research team led by Dr. Xujiong Ye at the University of California, San Diego. The team used a variety of techniques, including RNA sequencing and bioinformatics analysis, to identify the molecule's unique characteristics and its potential as a drug target.

\"We were surprised to find that LINC02874 was highly expressed in a variety of human tissues and that it was involved in the regulation of cell growth, apoptosis, and inflammation,\" Dr. Ye said. \"We believe that LINC02874 has the potential to be a valuable drug target for the treatment of various diseases.\"

In addition to its potential as a drug target, LINC02874 has also been shown to have a number of potential applications in cancer research. For example, the molecule has been shown to be downregulated in various types of cancer, which suggests that it may have potential as a therapeutic target for these diseases. Additionally, the molecule has been shown to play a role in the regulation of cell cycle progression, which is a critical step in the development and progression of cancer.

The potential applications of LINC02874 as a drug target are vast and continue to be explored by researchers. The molecule has been shown to have potential in the treatment of a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

In conclusion, LINC02874 is a promising molecule with potential as a drug target for the treatment of various diseases. Further research is needed to fully understand its unique characteristics and its potential as a therapeutic agent.

Protein Name: Long Intergenic Non-protein Coding RNA 2874

More Common Targets